查看完整行情页>>
|
货币单位:美元(USD)
立派制药
Cubist Pharmaceuticals LLC (cbst)
| 开盘价:-- |
最高价:-- |
最低价:-- |
52周最高价:-- |
52周最低价:-- |
| 成交量:-- |
平均成交量:-- |
市值:-- |
市盈率:-- |
预期市盈率:-- |
| 每股收益:-- |
贝塔系数:-- |
股息:-- |
收益率:-- |
总股本:-- |
| 机构持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| FMR LLC |
7752678 |
4.00% |
526251783 |
0.10% |
1999-11-30
|
| BlackRock,Inc. |
7595326 |
4.00% |
515570729 |
0.10% |
1999-11-30
|
| Wellington Management Company,LLP |
6100237 |
4.00% |
414084088 |
0.10% |
1999-11-30
|
| Putnam Investments,LLC |
5605513 |
4.00% |
380502222 |
0.10% |
1999-11-30
|
| The Vanguard Group,Inc. |
4331194 |
4.00% |
294001449 |
0.10% |
1999-11-30
|
| 共同基金持股 |
| 持有者 |
持有份额 |
持股比例 |
份额变化 |
变化率 |
报告日期 |
| Putnam Capital Spectrum Fund |
4681368 |
6.20% |
579996 |
14.10% |
2014-09-30
|
| Hartford MidCap Fund |
769319 |
1.00% |
6159 |
0.80% |
2014-11-30
|
| Vanguard Small Cap Growth Index Fund |
874111 |
1.10% |
-10379 |
-1.20% |
2014-12-31
|
| iShares Nasdaq Biotechnology |
875786 |
1.20% |
-17910 |
-2.00% |
2015-01-15
|
| Fidelity® Capital Appreciation Fund |
899712 |
1.20% |
-- |
-- |
2014-11-30
|
| iShares Core S&P Mid-Cap (AU) |
1134358 |
1.50% |
1690 |
0.20% |
2015-01-15
|
| First Trust NYSE Arca Biotech Fund |
1138320 |
1.50% |
156147 |
15.90% |
2015-01-15
|
| Vanguard Total Stock Mkt Idx |
1252292 |
1.60% |
3428 |
0.30% |
2014-11-30
|
| Fidelity® Select Biotechnology Portfolio |
1275519 |
1.70% |
-- |
-- |
2014-11-30
|
| Vanguard Small Cap Index |
1333756 |
1.80% |
3872 |
0.30% |
2014-12-31
|
| Fidelity® Select Health Care Portfolio |
1426314 |
1.90% |
3674 |
0.30% |
2014-11-30
|
| Federated Kaufmann Fund |
1600000 |
2.10% |
-- |
-- |
2014-09-30
|
| Vanguard Health Care Fund |
1977342 |
2.60% |
509800 |
34.70% |
2014-09-30
|
| Putnam Equity Spectrum Fund |
2152083 |
2.80% |
290708 |
15.60% |
2014-09-30
|
| T. Rowe Price Mid Cap Growth Fund |
750000 |
1.00% |
75000 |
11.10% |
2014-09-30
|
